JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (7): 12-16.doi: 10.6040/j.issn.1671-7554.0.2016.1655

Previous Articles     Next Articles

Expression of CSN5 and its correlation with the prognosis of gastric carcinoma

ZONG Shuai, XIAO Dongjie, LIU Hua, JIA Yanfei, MA Xiaoli, LI Huanjie, LI Ping, ZHENG Yan, WANG Yunshan   

  1. Central Laboratory of Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China
  • Received:2016-12-13 Online:2017-07-10 Published:2017-07-10

PDF (PC)

272

Abstract: Objective To investigate the expression of CSN5 in gastric carcinoma(GC)and to determine the prognostic value of CSN5 for GC patients. Methods The genomic alternation of CSN5 was assessed using cBioportal analytical tool. CSN5 mRNA expressions in normal gastric cell line and GC cell line were determined using qRT-PCR. The differences of CSN5 mRNA expressions in gastric mucosa and GC tissues were analyzed based on Oncomine database and TCGA database. The association between CSN5 and prognosis of GC patients was determined with Kaplan-Meier plotter. The relationship between CSN5 expression and 5-year survival of GC patients was analyzed using Chen gastric statistics. Results CSN5 was mainly amplified in GC. The mRNA expression of CSN5 was significantly higher in cancer cell lines than in normal gastric cell line, and was significantly higher in GC tissues than in normal gastric mucosa. Patients with high expression of CSN5 had longer overall survival(OS)than those with low expression. Conclusion The expression of CSN5 is elevated in GC tissues, which is also positively correlated with OS of GC patients.

Key words: Constitutive photomorphogenesis 9 signalosome, Prognosis, Gastric cancer

CLC Number: 

  • R735.2
[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] Elimova E, Wadhwa R, Shiozaki H, et al. Molecular biomarkers in gastric cancer[J]. J Natl Compr Canc Netw, 2015, 13(4): e19-29.
[4] Cristescu R, Lee J, Nebozhyn M, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes[J]. Nat Med, 2015, 21(5): 449-456.
[5] Wei N, Deng XW. The COP9: a new genetic locus involved in light- regulated development and gene expression in arabidopsis[J]. Plant Cell, 1992, 4(12): 1507-1518.
[6] Zhao R, Yeung SC, Chen J, et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers[J]. J Clin Invest, 2011, 121(3): 851-865.
[7] Yang X, Menon S, Lykke-Andersen K, et al. The COP9 signalosome inhibits p27(kip1)degradation and impedes G1- S phase progression via deneddylation of SCF Cul1[J]. Curr Biol, 2002, 12(8): 667-672.
[8] Zhang XC, Chen J, Su CH, et al. Roles for CSN5 in control of p53/MDM2 activities[J]. J Cell Biochem, 2008, 103(4): 1219-1230.
[9] Xue Y, Chen J, Choi HH, et al. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53[J]. Cell Cycle, 2012, 11(22): 4181-4190.
[10] Fang L, Lu W, Choi HH, et al. ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development[J]. Cancer Cell, 2015, 28(2): 183-197.
[11] Gao S, Fang L, Phan LM, et al. COP9 signalosome subunit 6(CSN6)regulates E6AP/UBE3A in cervical cancer[J].Oncotarget,2015,6(29):28026-28041. doi: 10.18632/oncotarget.4731.
[12] Li L, Deng XW. The COP9 signalosome: an alternative lid for the 26S proteasome?[J]. Trends Cell Biol, 2003, 13(10): 507-509.
[13] Kouvaraki MA, Rassidakis GZ, Tian L, et al. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1)[J]. Cancer Res, 2003, 63(11): 2977-2981.
[14] Sun L, Dong Y, Ohno M, et al. Jab1 expression is associated with inverse expression of p27(kip1)and poor prognosis in epithelial ovarian tumors[J]. Clin Cancer Res, 2001, 7(12): 4130-4135.
[15] Pan Y, Wang S, Su B, et al. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression[J]. Oncogene, 2017, 36(8): 1069-1079.
[16] Tomoda K, Kubota Y, Arata Y, et al. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex[J]. J Biol Chem, 2002, 277(3): 2302-2310.
[17] Pan Y, Zhang Q, Tian L, et al. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma[J]. Cancer Res, 2012, 72(7): 1890-1900.
[18] Sang MM, Du WQ, Zhang RY, et al. Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways[J]. Bioorg Med Chem Lett, 2015, 25(15): 2897-2901.
[19] Duda DM, Borg LA, Scott DC, et al. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation[J]. Cell, 2008, 134(6): 995-1006.
[20] Gusmaroli G, Figueroa P, Serino G, et al. Role of the MPN subunits in COP9 signalosome assembly and activity, and their regulatory interaction with Arabidopsis Cullin3-based E3 ligases[J]. Plant Cell, 2007, 19(2): 564-581.
[21] Cope GA, Suh GS, Aravind L, et al. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1[J]. Science, 2002, 298(5593): 608-611.
[22] Dominguez-Sola D, Dalla-Favera R. PINning down the c-Myc oncoprotein[J]. Nat Cell Biol, 2004, 6(4): 288-289.
[23] Chen J, Shin JH, Zhao, et al. CSN6 drives carcinogenesis by positively regulating Myc stability[J]. Nat Commun, 2014, 5: 5384. doi: 10.1038/ncomms6384.
[24] Karlsson A, Deb-Basu D, Cherry A, et al. Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression[J]. Proc Natl Acad Sci U S A, 2003, 100(17): 9974-9979.
[25] Felsher DW, Bishop JM. Transient excess of MYC activity can elicit genomic instability and tumorigenesis[J]. Proc Natl Acad Sci U S A, 1999, 96(7): 3940-3944.
[26] Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins[J]. Nat Rev Mol Cell Biol, 2005, 6(8): 635-645.
[27] Guo H, Jing L, Cheng Y, et al. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis[J]. Hepatology, 2016, 63(3): 898-913.
[1] LI Yinglin, SONG Daoqing, XU Zhonghua. Identification of FKBP11 expression in clear cell renal cell carcinoma using bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 45-51.
[2] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47-52.
[3] DI Xuemin, NIU Shulei, ZHAO Jing, DU Sui, YU Huimin, ZHANG Hongtao, WANG Juan. CT-guided 125I seed implantation for lymph node metastases in patients with gastric cancer of later stage [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 79-84.
[4] LI Xingkai, LIU Zhanye, JIANG Yunfeng, LI Jun. Clinicopathological factors and prognosis between primary central and peripheral lung squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 73-78.
[5] SUN Qijing, CHEN Fangfang, LI Chunxiao, ZHANG Caiqing. Clinical value of PNI and HGB in evaluating the prognosis of the middle to late stage non-small cell lung cancer patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 55-59.
[6] LIN Jiaxiang, GUO Zijia, SU Peng, WANG Xiao, GUO Yaxin, WU Xiaojuan, XIANG Lei, ZHOU Zhiqiang, WANG Yan, CUI Xiujie, PAN Aifeng, GUO Chenghao. The role of CIP2A in the transformation of breast ductal epithelium and prognosis of invasive breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 100-106.
[7] ZHOU Lanlan, PAN Xueyi, GUO Yu. Clinical characteristics and prognosis of 48 patients with mixed phenotype acute leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 79-83.
[8] ZHANG Xiying, ZHAI Chunyan, LI Jingsong, HAN Bo. Expression of EZH2 in Chinese Ewing sarcoma patients and its relationship with clinicopathological parameters and prognosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 84-91.
[9] LIU Huiling, WANG Xingwen, FENG Shaobin, FENG Hong, HAN Junqing. Association between high expression of scavenger receptor class B type I and the prognosis of colon cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 84-89.
[10] LI Xiaoning, CUI Lianqun. Treatment timing of non-infarct-related artery in patients with multi-vessel disease and acute myocardial infarction [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 50-54.
[11] WANG Wen, LIU Yao, LONG Fei, MA Weixia, SU Lili. Correlation between lymphocyte-to-monocyte ratio in peripheral blood and prognosis of malignant pleural mesothelioma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 72-77.
[12] LIU Tong, ZHANG Xin, WANG Chuanxin. Significance of IRX5 mRNA in the diagnosis and prognosis of colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 69-74.
[13] DONG Xiuhong. Effect of cognitive-behavioral therapy plus hypnosis in controlling cancer-related fatigue in gastric cancer patients receiving chemotherapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 56-59.
[14] MA Lin, ZHANG Dong, TANG Lei, YE Siyuan, YAN Chuanzhu, CAO Lili. Prognostic hematological biomarkers of amyotrophic lateral sclerosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 46-50.
[15] XU Zhihong, WU Xiaohua, YAO Tiezhu, WANG Xiaoxiang, DUAN Xiaoyang, SHI Jian. Relationship between mir-99a expression and prognosis of epithelial ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 77-80.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd